Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers.
Press Releases
25 Jun 2019The Medicines Company Announces Pricing of Public Offering of Common Stock24 Jun 2019The Medicines Company Announces Launch of Public Offering of Common Stock27 May 2019The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.
Recent Events
Date
Event Details